Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spectrum Pharma Inc (NQ: SPPI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Spectrum Pharma Inc

< Previous 1 2 3 4 5 6 7 8 Next >
SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI
From Kahn Swick & Foti, LLC
Via Business Wire
Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer
Palm Beach, FL – March 24, 2022 – FinancialNewsMedia.com News Commentary – The status of breast cancer as one of the most commonly occurring cancers in the world is expected to be a key driving factor... 
Via FinancialNewsMedia
Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Alert: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 02/15/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors, who purchased shares of Spectrum Pharmaceuticals, Inc.... 
Via SBWire
Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Announces Strategic Restructuring
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 11/17/2021 -- An investigation on behalf of current long-term investors in shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) concerning potential breaches of fiduciary... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders
From Robbins LLP
Via Business Wire
FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
CLASS ACTION UPDATE for SPPI, APPH and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.